2.74
13.22%
0.32
Handel nachbörslich:
2.74
Finanzdaten der Puma Biotechnology Inc-Aktie (PBYI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
39.36%
43.77
|
72.18 | 56.12 | 54.57 | 52.77 |
Cost Of Revenue |
55.89%
10.73
|
24.32 | 13.28 | 11.86 | 13.22 |
Gross Profit |
30.96%
33.04
|
47.85 | 42.83 | 42.71 | 39.56 |
Operating Expenses
|
6.90%
35.34
|
33.06 | 34.25 | 37.82 | 35.19 |
Interest Income/Expense |
0.15%
3.359
|
3.354 | 3.339 | 3.325 | 3.312 |
Benefits Costs and Expenses |
18.55%
48.36
|
59.37 | 50.11 | 52.26 | 51.23 |
Costs And Expenses |
19.72%
46.06
|
57.38 | 47.53 | 49.68 | 48.41 |
Depreciation and Amortization |
0.28%
2.897
|
2.889 | 2.876 | 2.876 | 2.878 |
Operating Income/Loss |
115.54%
-2.299
|
14.80 | 8.585 | 4.892 | 4.365 |
Nonoperating Income/Loss |
15.15%
-2.296
|
-1.994 | -2.576 | -2.579 | -2.817 |
Income/Loss From Continuing Operations Before Tax |
135.89%
-4.595
|
12.80 | 6.009 | 2.313 | 1.548 |
Income Tax Expense/Benefit |
58.96%
0.22
|
0.536 | 0.213 | 0.187 | 0.147 |
Income/Loss From Continuing Operations After Tax |
139.25%
-4.815
|
12.27 | 5.796 | 2.126 | 1.401 |
Net Income/Loss
|
139.25%
-4.815
|
12.27 | 5.796 | 2.126 | 1.401 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
30,554%
48.19
|
0.1572 | 47.52 | 46.76 | 46.64 |
Diluted Average Shares |
31,264%
48.19
|
0.1536 | 47.82 | 47.20 | 47.16 |
Basic Earnings Per Share |
138.46%
-0.10
|
0.26 | 0.12 | 0.05 | 0.03 |
Diluted Earnings Per Share |
140.00%
-0.10
|
0.25 | 0.12 | 0.05 | 0.03 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):